Paper35720690
Effects of Bilateral Subthalamic Nucleus Stimulation on Depressive Symptoms and Cerebral Glucose Metabolism in Parkinson's Disease: A 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography Study.
Zhang X and 9 others. Front Neurosci, 2022. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Effects of Bilateral Subthalamic Nucleus Stimulation on Depressive Symptoms and Cerebral Glucose Metabolism in Parkinson's Disease: A 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography Study. Papers, record 35720690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35720690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Effects of Bilateral Subthalamic Nucleus Stimulation on Depressive Symptoms and Cerebral Glucose Metabolism in Parkinson's Disease: A 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/P008747/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24314926 | Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. | J Affect Disord | 2014 | https://conductscience.org/library/papers/24314926 | PubMed |
| 2 | 28320164 | Impact of STN-DBS on mood, drive, anhedonia and risk of psychiatric side-effects in the population of PD patients. | J Neurol Sci | 2017 | https://conductscience.org/library/papers/28320164 | PubMed |
| 3 | 23529021 | Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging. | Parkinsonism Relat Disord | 2013 | https://conductscience.org/library/papers/23529021 | PubMed |
| 4 | 26555494 | Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression. | Compr Psychiatry | 2015 | https://conductscience.org/library/papers/26555494 | PubMed |
| 5 | 29719720 | Chinese expert consensus on programming deep brain stimulation for patients with Parkinson's disease. | Transl Neurodegener | 2018 | https://conductscience.org/library/papers/29719720 | PubMed |
| 6 | 17217926 | Diurnal variation in regional brain glucose metabolism in depression. | Biol Psychiatry | 2007 | https://conductscience.org/library/papers/17217926 | PubMed |
| 7 | 28571034 | Remotely Programmed Deep Brain Stimulation of the Bilateral Subthalamic Nucleus for the Treatment of Primary Parkinson Disease: A Randomized Controlled Trial Investigating the Safety and Efficacy of a Novel Deep Brain Stimulation System. | Stereotact Funct Neurosurg | 2017 | https://conductscience.org/library/papers/28571034 | PubMed |
| 8 | 21069833 | Systematic review of levodopa dose equivalency reporting in Parkinson's disease. | Mov Disord | 2010 | https://conductscience.org/library/papers/21069833 | PubMed |
| 9 | 31293511 | Acute Effects of Subthalamic Deep Brain Stimulation on Motor Outcomes in Parkinson's Disease; 13 Year Follow Up. | Front Neurol | 2019 | https://conductscience.org/library/papers/31293511 | PubMed |
| 10 | 22198405 | Depression in Parkinson disease--epidemiology, mechanisms and management. | Nat Rev Neurol | 2011 | https://conductscience.org/library/papers/22198405 | PubMed |
| 11 | 11904133 | Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. | Biol Psychiatry | 2002 | https://conductscience.org/library/papers/11904133 | PubMed |
| 12 | 15338272 | Stages in the development of Parkinson's disease-related pathology. | Cell Tissue Res | 2004 | https://conductscience.org/library/papers/15338272 | PubMed |
| 13 | 12112190 | Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. | Mov Disord | 2002 | https://conductscience.org/library/papers/12112190 | PubMed |
| 14 | 28259880 | Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation. | Stereotact Funct Neurosurg | 2017 | https://conductscience.org/library/papers/28259880 | PubMed |
| 15 | 9276848 | Limbic-cortical dysregulation: a proposed model of depression. | J Neuropsychiatry Clin Neurosci | 1997 | https://conductscience.org/library/papers/9276848 | PubMed |
| 16 | 16249050 | The functional role of the subthalamic nucleus in cognitive and limbic circuits. | Prog Neurobiol | 2005 | https://conductscience.org/library/papers/16249050 | PubMed |
| 17 | 19398020 | Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. | Neuroimage | 2009 | https://conductscience.org/library/papers/19398020 | PubMed |
| 18 | 22553030 | Connectivity-based parcellation of the human orbitofrontal cortex. | J Neurosci | 2012 | https://conductscience.org/library/papers/22553030 | PubMed |
| 19 | 30778210 | Long-term outcomes of deep brain stimulation in Parkinson disease. | Nat Rev Neurol | 2019 | https://conductscience.org/library/papers/30778210 | PubMed |
| 20 | 19933974 | Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. | Neurology | 2009 | https://conductscience.org/library/papers/19933974 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909311 | Deep brain stimulation as neuroimmune-metabolic modulation in Parkinson's disease and beyond: tissue response, glial remodeling, and disease modification. | Front Immunol | 2026 | https://conductscience.org/library/papers/42909311 | PubMed |
| 42831145 | Deep brain stimulation mechanisms in comorbid pain and emotional dysregulation from animal models. | iScience | 2026 | https://conductscience.org/library/papers/42831145 | PubMed |
| 42667351 | Mechanism and progress of deep brain stimulation in the treatment of neurological and psychiatric disorders. | MedScience | 2026 | https://conductscience.org/library/papers/42667351 | PubMed |
| 42006781 | Meta analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profiles. | medRxiv | 2026 | https://conductscience.org/library/papers/42006781 | PubMed |
| 37130665 | Efficacy of non-pharmacological interventions on depressive symptoms in patients with Parkinson's disease: a study protocol for a systematic review and network meta-analysis. | BMJ Open | 2023 | https://conductscience.org/library/papers/37130665 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35720690
GET https://conductscience.org/api/papers/v1/35720690/references?page=2